Eloctate with Fc Fusion Protein recombinant and Glipizide and metformin

• Generic Name: antihemophilic factor
• Dosage Forms: n.a.
• Other Brand Names: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur

Eloctate with Fc Fusion Protein is a naturally occurring protein in the blood that helps blood to clot. A lack of antihemophilic factor VIII is the cause of hemophilia A. Recombinant this medicine works by temporarily raising levels of factor VIII in the blood to aid in clotting.

Recombinant Eloctate with Fc Fusion Protein is used to treat or prevent bleeding episodes in adults and children with hemophilia A. It is also used to control bleeding related to surgery or dentistry in a person with hemophilia, and to prevent joint damage in people age 16 or older with severe hemophilia A and no prior joint damage.

Recombinant Eloctate with Fc Fusion Protein is not for use in people with von Willebrand disease.

Recombinant Eloctate with Fc Fusion Protein may also be used for purposes not listed in this medication guide.

• Generic Name: glipizide / metformin
• Dosage Forms: n.a.
• Other Brand Names: Metaglip

Glipizide and metformin is a combination of two oral diabetes medicines that help control blood sugar levels.

Glipizide and metformin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes. glipizide and metformin is not for treating type 1 diabetes.

Glipizide and metformin may also be used for purposes not listed in this medication guide.